Clinical trial
Setmelanotide in a Single Patient With Partial Lipodystrophy
NCT03262610
Study timeline
Study start (actual)2017-08-15Date precision: day
Registry last updated2022-01-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertriglyceridemiaunresolved
Obesityunresolved
Interventions
SetmelanotideDRUG · verified · RxNorm: setmelanotide
Sponsors & collaborators
Rhythm Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03262610 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.